Authors: | Pietanza, M. C.; Ladanyi, M. |
Article Title: | Bringing the genomic landscape of small-cell lung cancer into focus |
Abstract: | Genomic characterization efforts in small-cell lung cancer have been complicated by the paucity of high-quality surgical resection specimens for this aggressive lung cancer subtype that is usually diagnosed at unresectable stages in small biopsies or cytology specimens. Now, two papers report genomic analyses of small-cell lung cancer, highlighting subsets of tumors driven by amplification of FGFR1, SOX2 or MYC family members or by a MYCL1 fusion oncogene, among many other recurrent alterations. © 2012 Nature America, Inc. All rights reserved. |
Keywords: | cancer survival; gene mutation; cisplatin; erlotinib; cancer combination chemotherapy; cancer growth; topotecan; recurrent cancer; antineoplastic agent; cytology; animals; carboplatin; quality of life; gene amplification; etoposide; lung non small cell cancer; lung neoplasms; tumor biopsy; mutational analysis; phosphatidylinositol 3 kinase; genome analysis; oncogene; lung adenocarcinoma; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; gefitinib; fusion gene; genome; inoperable cancer; cancer tissue; lung squamous cell carcinoma; oncogene c myc; lung biopsy; transcription factor sox2; soxb1 transcription factors; genetic marker; fibroblast growth factor receptor 1; genome, human; genetic heterogeneity; small cell lung carcinoma; crizotinib; fgfr1 gene; sox2 gene; mycl1 gene; rlf mycl1 fusion gene |
Journal Title: | Nature Genetics |
Volume: | 44 |
Issue: | 10 |
ISSN: | 1061-4036 |
Publisher: | Nature Publishing Group |
Date Published: | 2012-10-01 |
Start Page: | 1074 |
End Page: | 1075 |
Language: | English |
DOI: | 10.1038/ng.2415 |
PROVIDER: | scopus |
PUBMED: | 23011222 |
DOI/URL: | |
Notes: | --- - "Export Date: 2 November 2012" - "CODEN: NGENE" - "Source: Scopus" |